VMD-928
NCT03556228
VM Oncology · Phase 1/2 · Recruiting · Enrollment 242
| Arm | Reported safety |
|---|
A count stays a count. This page does not turn a count into a percent.
ACC
Programs, trials, and reported response and survival for adenoid cystic carcinoma.
VMD-928
VM Oncology · Phase 1/2 · Recruiting · Enrollment 242
| Arm | Reported safety |
|---|
A count stays a count. This page does not turn a count into a percent.